印度脐带血银行服务市场：依服务类型、组件、储存类型、应用、最终用户、地区、机会和预测，2018-2032年

印度脐带血银行服务市场规模预计将从2024年的1.3255亿美元成长到2032年的2.4084亿美元，预测期内（2025-2032年）的年复合成长率为 7.75%。

由于最近的技术进步和对高效解决方案的需求不断增加，印度脐带血银行服务市场经历显着成长。推动该国市场扩张的主要因素之一是由于久坐的生活方式和不断变化的环境条件导致大多数人口的生殖功能下降。围绕女性不孕症的禁忌现在解除了，随着意识在全国范围内传播，人们可以更自由地利用这些医疗选择。此外，政府对医疗保健基础设施的投资、技术进步以及对尖端解决方案的需求不断成长也增强了市场的成长轨迹。医疗保健领域的快速发展，尤其是亚太地区的快速发展，提供了良好的前景。例如，印度最大、最负盛名的干细胞银行 LifeCell International Limited 于2023年 11月以全球最低价推出了一项突破性的干细胞银行解决方案。这项突破性的产品以脐带血干细胞为基础，过去 25年来已在全球成功完成超过 30,000 例移植手术。此次发布恰逢全球庆祝脐带血干细胞治疗25週年。

本报告研究了印度脐带血银行服务市场，并概述了市场及其主要细分市场，包括服务类型、组件、储存类型、应用、最终用户、区域趋势和公司概况。

目录

第1章 专案范围与定义

第2章 研究方法

第3章 执行摘要

第4章 印度脐带血银行服务市场的前景，2018年～2032年

• 市场规模分析及预测
• 市场占有率分析及预测
• 2024年市场地图分析
  • 依服务类型
  • 依组件
  • 依储存类型
  • 依用途
  • 依最终用户
  • 依地区

第5章 需求与供给分析

第6章 波特五力分析

第7章 PESTLE 分析

第8章 定价分析

第9章 市场动态

第10章 市场趋势与发展

第11章 案例研究

第12章 竞争格局

• 五大市场领导者的竞争矩阵
• 五大公司的SWOT分析
• 市场前十大主要公司的状况
  • Cordlife India Private Limited
  • LifeCell International Private Limited
  • Cryoviva Biotech India Private Limited
  • StemCyte India Therapeutics Private Limited
  • Reliance Life Sciences Private Limited
  • BabyCell India Private Limited
  • CReATe Cord Blood Bank
  • CryoVault Biotech India Private Limited
  • NovaCord Stem Cell Bank
  • ReeLabs Stem Cell Bank

第13章 策略建议

第14章 关于调查公司/免责声明

India cord blood banking services market is projected to witness a CAGR of 7.75% during the forecast period FY2025-FY2032, growing from USD 132.55 million in FY2024 to USD 240.84 million in FY2032.

India market for cord blood banking services has grown significantly because of recent advancements in technologies and the growing demand for efficient solutions. One of the primary factors propelling market expansions in the country is most of the population's declining reproductive health owing to the sedentary lifestyles and shifting environmental conditions. The taboo that is still associated with infertility issues in women are now dissolving, and people are more freely availing these medical options as awareness spreads more around the country. Furthermore, the market's growth trajectory is being reinforced by government investments in healthcare infrastructure, advancements in technology, and the growing demand for cutting-edge solutions. Rapid advancements in healthcare, particularly in Asia-Pacific, present lucrative prospects. For example, the largest and most reputable stem cell bank in India, LifeCell International Limited, unveiled a revolutionary stem cell banking solution in November 2023 at the lowest cost in the world. The key component of this novel product is umbilical cord blood stem cells, which have been utilized in more than 30,000 successful transplants globally over the previous 25 years. This launch coincides with the global observance of the 25th anniversary of umbilical cord blood stem cell treatments.

Scientific Innovations Boosting Market Growth

One of the main factors propelling the growth of India cord blood banking services market is the advancements in stem cell research. The scientific community has advanced our knowledge of the therapeutic potential of stem cells, particularly those present in cord blood, over the years. Numerous illnesses, including leukemia, sickle cell anemia, and even some neurological disorders, can be treated with stem cells. Expectant parents are interested in the increasing amount of evidence that supports the clinical use of cord blood stem cells in immunotherapy, gene therapy, and regenerative medicine. Since cord blood storage may one day lead to life-saving treatments, this increase in scientific support has increased its appeal. As a result, more families opt to store their newborn's cord blood, fostering the growth of cord blood banking services in India. StemCyte India Therapeutics Pvt. Ltd. has adopted a hybrid banking model that combines private and public banking. This model enhances sustainability and expands the potential for stem cell utilization, making it a comprehensive approach to cord blood banking.

Improvements in Healthcare Infrastructure Boosting Market Growth

An important factor driving the expansion of the cord blood banking market in India is the ongoing development of the country's healthcare system. The emergence of cutting-edge healthcare facilities, such as clinics, hospitals, and private healthcare providers offering specialized services, has made cord blood banking more widely available. The safe collection, processing, and storage of cord blood is guaranteed by the growing availability of cutting-edge medical technologies. Additionally, the market's consumers have grown as healthcare services have expanded in both urban and rural locations. The need for cord blood banking services rises as more healthcare facilities and hospitals incorporate it into their services. Moreover, the government's investment in healthcare infrastructure has improved public and private partnerships, providing better healthcare delivery, which indirectly boosts the awareness and uptake of cord blood banking services. For instance, in October 2023, the Singapore Exchange-listed Cordlife Group Limited established its Indian affiliate - Cordlife Sciences India Pvt Ltd, an advanced diagnostic laboratory in Kolkata. The purpose of this new facility is to serve as a testing center for Cordlife India, meeting the medical needs of the company's current stem cell banking customers and their families as well as those of surrounding patients, medical professionals, and doctors.

Government Initiatives Fueling the Market Growth

Government initiatives and support have been an important factor in the growth of the India cord blood banking services market. Indian government's focus on biotechnology and healthcare is creating a conducive environment for the expansion of stem cell-based services, including cord blood banking. Various government-backed programs and policies are aimed at boosting the biotechnology sector, with a specific focus on stem cell research and applications. Additionally, the government's efforts in spreading awareness about stem cell therapies have enhanced public interest in preserving cord blood for future medical use. Initiatives such as funding for research, collaborations with international biotech firms, and regulatory frameworks to ensure ethical practices are further accelerating market growth. Moreover, government support in improving healthcare accessibility, funding public awareness campaigns, and encouraging investment in stem cell technology have all contributed to making cord blood banking services more available and affordable to the Indian population. For example, the Indian government enhanced stem cell research in February 2022, by utilizing a number of departments and institutions. National funding organizations including the Department of Biotechnology (DBT), the Department of Science and Technology (DST), and the Indian Council of Medical Research (ICMR) provided assistance for both basic and clinical research as part of this endeavour. In addition to supporting industrial activities in India, these measures have resulted in the construction of state-of-the-art facilities at over 40 prestigious health research and educational institutes.

Future Market Scenario (FY2025 - FY2032F)

Many factors claim the growth of India cord blood banking services market. Technological advancements give faster and more accurate results leading us to early diagnosis. Opportunity also lies in the increasing number of fertility concerns that the population is facing today. Promising initiatives of our government that provide healthcare infrastructure, funds to carry on research and development on a large scale, and a reliable distribution channel that ensures the solution reaches everyone is testimonial. For instance, from primary healthcare facilities to sophisticated tertiary care hospitals, India currently has a vast healthcare infrastructure. One of the biggest healthcare systems in the world is expected to grow because of increased public and private sector investment. To increase access to high-quality healthcare for a larger portion of the population, developers are currently collaborating with healthcare providers to build cutting-edge facilities in tier 2 and tier 3 cities as well as metropolitan areas.

Key Players Landscape and Outlook

Key players in the cord blood banking services industry utilize strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, to increase shareholder value, Cryo-Cell International, Inc. announced in March 2024 that it will spin off its subsidiary, Celle Corp. This can positively impact the cord blood banking services in India by being able to expand further and bring cutting-edge technology which will open the room for this market to grow.

Recent advancements indicate that stem cell research is a top focus in India. The US-based company StemCures stated in May 2023 that it will invest a substantial $54 million to build the largest stem cell production facility in India in Hyderabad. Furthermore, Stempeutics Research Pvt. Ltd. has achieved great progress by bringing India's first allogeneic stem cell therapy, Stempeucel, to market. This ground-breaking treatment is intended to restore blood flow in ischemic areas, giving patients all over the world hope.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Cord Blood Banking Services Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Service Type
    • 4.2.1.1. Sample Preservation and Storage
    • 4.2.1.2. Sample Analysis
    • 4.2.1.3. Sample Processing
    • 4.2.1.4. Sample Collection and Transportation
  • 4.2.2. By Component
    • 4.2.2.1. Cord Blood
    • 4.2.2.2. Cord Tissue
  • 4.2.3. By Storage Type
    • 4.2.3.1. Public Cord Blood Banks
    • 4.2.3.2. Private Cord Blood Banks
  • 4.2.4. By Application
    • 4.2.4.1. Cancer
    • 4.2.4.2. Blood Disorders
    • 4.2.4.3. Fertility Disorders
    • 4.2.4.4. Immune Disorders
    • 4.2.4.5. Others
  • 4.2.5. By End-user
    • 4.2.5.1. Hospitals
    • 4.2.5.2. Research Institutes and Academic Centers
    • 4.2.5.3. Fertility Clinics
    • 4.2.5.4. Others
  • 4.2.6. By Region
    • 4.2.6.1. North
    • 4.2.6.2. South
    • 4.2.6.3. East
    • 4.2.6.4. West and Central
  • 4.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Service Type
  • 4.3.2. By Component
  • 4.3.3. By Storage Type
  • 4.3.4. By Application
  • 4.3.5. By End-user
  • 4.3.6. By Region

All segments will be provided for all regions and countries covered

5. Demand Supply Analysis

6. Porter's Five Forces Analysis

7. PESTLE Analysis

8. Pricing Analysis

9. Market Dynamics

• 9.1. Market Drivers
• 9.2. Market Challenges

10. Market Trends and Developments

11. Case Studies

12. Competitive Landscape

• 12.1. Competition Matrix of Top 5 Market Leaders
• 12.2. SWOT Analysis for Top 5 Players
• 12.3. Key Players Landscape for Top 10 Market Players
  • 12.3.1. Cordlife India Private Limited
    • 12.3.1.1. Company Details
    • 12.3.1.2. Key Management Personnel
    • 12.3.1.3. Products and Services
    • 12.3.1.4. Financials (As Reported)
    • 12.3.1.5. Key Market Focus and Geographical Presence
    • 12.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 12.3.2. LifeCell International Private Limited
  • 12.3.3. Cryoviva Biotech India Private Limited
  • 12.3.4. StemCyte India Therapeutics Private Limited
  • 12.3.5. Reliance Life Sciences Private Limited
  • 12.3.6. BabyCell India Private Limited
  • 12.3.7. CReATe Cord Blood Bank
  • 12.3.8. CryoVault Biotech India Private Limited
  • 12.3.9. NovaCord Stem Cell Bank
  • 12.3.10. ReeLabs Stem Cell Bank

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

13. Strategic Recommendations

14. About Us and Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Cord Blood Banking Services Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. India Cord Blood Banking Services Market Share (%), By Service Type, FY2018-FY2032F
• Figure 3. India Cord Blood Banking Services Market Share (%), By Component, FY2018-FY2032F
• Figure 4. India Cord Blood Banking Services Market Share (%), By Storage Type, FY2018-FY2032F
• Figure 5. India Cord Blood Banking Services Market Share (%), By Application, FY2018-FY2032F
• Figure 6. India Cord Blood Banking Services Market Share (%), By End-user, FY2018-FY2032F
• Figure 7. India Cord Blood Banking Services Market Share (%), By Region, FY2018-FY2032F
• Figure 8. By Service Type Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By Component Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 10. By Storage Type Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 11. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 12. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 13. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024